Table of Contents

Volume 7, Issue 1

  January 2008

  Pages 1 - 154

View covers archive

Editor's Corner

• Cover Image

  
  

Review

• Biology of breast cancer bone metastasis

  Mojtaba Akhtari, Junaid Mansuri, Kam A. Newman, Theresa M. Guise and Prem Seth
  Pages 1 - 7

Journal Club

• HIF-1α and STAT3 client proteins interacting with the cancer chaperone Hsp90: Therapeutic considerations

  Hanna Leah Kim, Marco Cassone, Laszlo Otvos Jr. and Paraskevi Vogiatzi
  Pages 8 - 12

Clinical Study

• Circulating biomarkers of bevacizumab activity in patients with breast cancer

  Neelima Denduluri, Sherry X. Yang, Arlene W. Berman, Diana Nguyen, David J. Liewehr, Seth M. Steinberg and Sandra M. Swain
  Pages 13 - 18

Commentary

• Biomarkers in breast cancer

  Heather McArthur and Maura Dickler
  Pages 19 - 20

Research Papers

• Genetic polymorphisms in OGG1 and their association with angiomyolipoma, a benign kidney tumor in patients with tuberous sclerosis

  Open Access Article

  Samy L. Habib, Elaine Danial, Subrata Nath, Jennifer Schneider, Christopher P. Jenkinson, Ravindranath Duggirala, Hanna E. Abboud and Farook Thameem
  Pages 21 - 25

• The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.

  Vanina Medina, Máximo Croci, Ernesto Crescenti, Nora Mohamad, Francisca Sanchez-Jiménez, Noelia Massari, Mariel Nuñez, Graciela Cricco, Gabriela Martin, Rosa Bergoc and Elena Rivera
  Pages 26 - 33

Commentary

• Histamine in cancer: The two faces of the coin

  Fabio Cianchi, Maria Cristina Vinci and Emanuela Masini
  Pages 34 - 35

Research Papers

• MDM2 displays differential activities dependent upon the activation status of NFκB

  Misty D. Cheney, Pamela P. McKenzie, Erin L. Volk, Liying Fan and Linda C. Harris
  Pages 36 - 42

• Expression and significance of HERG protein in gastric cancer

  Xiao-Dong Shao, Kai-Chun Wu, Xiao-Zhong Guo, Man-Jiang Xie, Jing Zhang and Dai-Ming Fan
  Pages 43 - 48

• Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

  Zhi-Ming Li, Wen-Qi Jiang, Zhen-Yu Zhu, Xiao-Feng Zhu, Jun-Min Zhou, Zong-Chao Liu, Da-Jun Yang and Zhong-Zhen Guan
  Pages 49 - 58

Commentary

• Targeting Bcl-xL enhances the cytotoxicity of chemotherapeutics

  Shulin Wang
  Pages 59 - 60

Research Papers

• The role of p53 in the trafficking of copper-64 to tumor cell nuclei

  Martin Eiblmaier, Laura A. Meyer and Carolyn J. Anderson
  Pages 61 - 67

• Downregulation of IgG Fc binding protein (FcγBP) in prostate cancer

  Mozammel H. Gazi, MeiLan He, John C. Cheville and Charles Y.F. Young
  Pages 68 - 73

• Bismuth-213 radioimmunotherapy with C595 anti–MUC1 monoclonal antibody in an ovarian cancer ascites model

  Emma Y. Song, Chang F Qu, Syed M.A. Rizvi, Chand Raja, Julia Beretov, Alfred Morgenstern, Christos Apostolidis, Frank Bruchertseifer and Alan Perkins
  Pages 74 - 78

Commentary

• Targeting the human MUC1 oncoprotein: A tale of two proteins

  Donald W. Kufe
  Pages 79 - 82

Research Papers

• Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancer

  Chandramani Pathak, Yogesh K. Jaiswal and Manjula Vinayak
  Pages 83 - 89

• The effectiveness of retinoic acid treatment in bladder cancer: Impact on recurrence, survival and TGFα and VEGF as end-point biomarkers.

  Diaa A. Hameed and Tarek H. El-Metwally
  Pages 90 - 98

Commentary

• Prevention of bladder cancer recurrence by retinoic acid-ketoconazole

  Yair Lotan and Rueben Lotan
  Pages 99 - 100

Research Paper

• Development of Ad-mda7/IL-24-resistant lung cancer cell lines

  Abujiang Pataer, Sunil Chada, Jack A. Roth, Kelly K. Hunt and Stephen G. Swisher
  Pages 101 - 106

Commentary

• Acquired and innate resistance to the cancer-specific apoptosis-inducing Cytokine, mda-7/IL-24: Not insurmountable therapeutic problems

  Devanand Sarkar, Paul Dent, David T. Curiel and Paul B. Fisher
  Pages 107 - 110

Research Papers

• Ciprofloxacin-induced G2 arrest and apoptosis in TK6 lymphoblastoid cells is not dependent on DNA double-strand break formation

  Daniel J. Smart, H. Dorota Halicka, Frank Traganos, Zbigniew Darzynkiewicz and Gary M. Williams
  Pages 111 - 117

• hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin

  Min Yang, Marian L. Waterman and Rainer K. Brachmann
  Pages 118 - 126

Commentary

• hADA2a and hADA3: new players in ß-catenin signaling

  Charles Lopez, Joshi Alumkal and Katy Van Hook
  Pages 127 - 128

Research Papers

• The effect of fatty acid-CoA ligase 4 on the growth of hepatic cancer cells

  Chuangying Hu, Liang Chen, Yong Jiang, Yi Li and Shaofeng Wang
  Pages 129 - 132

• Allele-specific expression in the germline of patients with familial pancreatic cancer: An unbiased approach to cancer gene discovery

  Aik Choon Tan, Jian-Bing Fan, Karikari Collins, Marina Bibikova, Eliza Wickham Garcia, Lixin Zhou, David Barker, David Serre, Georg Feldmann, Ralph H. Hruban, Alison P. Klein, Michael Goggins, Fergus J. Couch, Thomas J. Hudson, Raimond L. Winslow, Anirban Maitra and Aravinda Chakravarti
  Pages 133 - 142

• Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic

  Nan Yang, Xiangying Zhu, Lishan Chen, Shenghua Li and Daming Ren
  Pages 143 - 149

Commentary

• Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy

  Meenhard Herlyn and Devraj Basu
  Pages 150 - 151